NEW YORK (AP) — NEW YORK (AP) — Syndax Pharmaceuticals Inc. (SNDX) on Thursday reported a loss of $68 million in its fourth quarter.
On a per-share basis, the New York-based company said it had a loss of 78 cents.
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.
The biopharmaceutical company posted revenue of $68.7 million in the period, which beat Street forecasts. Four analysts surveyed by Zacks expected $62.4 million.
For the year, the company reported a loss of $285.4 million, or $3.29 per share. Revenue was reported as $172.4 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SNDX at https://www.zacks.com/ap/SNDX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
